会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明授权
    • Imidazolidine derivative and use thereof
    • 咪唑烷衍生物及其用途
    • US5691335A
    • 1997-11-25
    • US615277
    • 1996-03-28
    • Harukazu FukamiMotoo SumidaShinjiro NiwataSaki KakutaniSaitoh MasayukiShibata HiroshiKiso Yoshinobu
    • Harukazu FukamiMotoo SumidaShinjiro NiwataSaki KakutaniSaitoh MasayukiShibata HiroshiKiso Yoshinobu
    • C07D233/80C07D233/84C07D233/86C07D401/04C07D403/04C07D405/12A61K31/415A61K31/495
    • C07D401/04C07D233/80C07D233/86C07D403/04C07D405/12
    • The invention relates to an imidazolidine derivative represented by the following general formula (1): ##STR1## wherein A and B mean individually an aromatic hydrocarbon group which may be substituted by 1-3 substituents selected from halogen atoms, C.sub.1-4 alkyl groups, C.sub.1-4 alkoxy groups, C.sub.1-4 alkylenedioxy groups, a phenoxy group, a nitro group, a cyano group, a phenyl group, C.sub.2-5 alkanoylamino groups, a carboxyl group which may be esterified with a C.sub.1-4 alkyl or alkenyl group, carboxyalkyl groups which may be esterified with a C.sub.1-4 alkyl or alkenyl group, carboxyalkyloxy groups which may be esterified with a C.sub.1-4 alkyl or alkenyl group, N-alkylpiperazinylcarbonyl groups, N-alkylpiperazinylcarbonylalkyl groups, N-alkylpiperazinylcarbonylalkyloxy groups, and a morpholinocarbonyl group; X denotes a sulfonyl or carbonyl group; and Y stands for an oxygen or sulfur atom, a chymase inhibitor comprising the same as an active ingredient, and a medicine comprising the same as an active ingredient, typified by a prophylactic and therapeutic agent for a disease of the heart or circulatory system, which is caused by the abnormal acceleration of production of angiotensin II.
    • PCT No.PCT / JP95 / 01485第 371日期:1996年3月28日 102(e)1996年3月28日PCT PCT 1995年7月26日PCT公布。 出版物WO96 / 04248 日期:1996年2月15日本发明涉及由以下通式(1)表示的咪唑烷衍生物:其中A和B分别表示可被1-3个选自以下的取代基取代的芳族烃基:卤素 原子,C 1-4烷基,C 1-4烷氧基,C 1-4亚烷基二氧基,苯氧基,硝基,氰基,苯基,C 2-5烷酰基氨基,可被酯化的羧基 可以被C 1-4烷基或链烯基酯化的羧基烷基,可被C 1-4烷基或链烯基酯化的羧基烷氧基,N-烷基哌嗪基羰基,N-烷基哌嗪基羰基烷基, ,N-烷基哌嗪基羰基烷氧基和吗啉代羰基; X表示磺酰基或羰基; Y表示氧或硫原子,包含与活性成分相同的胃促胰酶抑制剂和包含其作为活性成分的药物,以心脏或循环系统疾病的预防和治疗剂为代表,其中 是由血管紧张素II的异常加速引起的。